AIP
BIVI icon

Ameritas Investment Partners’s BioVie BIVI Stock Holding History

Ameritas Investment Partners’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$145 – 3137
2024
Q1 		$145 Hold
3
– – ﹤0.01% 3058
2023
Q4 		$345 Hold
3
– – ﹤0.01% 3083
2023
Q3 		$934 Hold
3
– – ﹤0.01% 3087
2023
Q2 		$1.18K Buy
+3
New +$2.02K ﹤0.01% 3098

Other funds holding BIVI

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Ameritas Investment Partners's BIVI Position: Q2 2024 in Review

Ameritas Investment Partners sold out of BioVie (BIVI) in Q2 2024, closing a stake of 3 shares — an estimated $145 sold.

Ameritas Investment Partners first reported a position in BIVI in Q2 2023 and held it in 4 quarters. The position peaked at $1.18K in Q2 2023. 48 funds tracked by Wall St. Rank hold BIVI as of Q2 2024.

  • Ameritas Investment Partners reported no remaining BioVie position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 3 BioVie shares in Q2 2024, an estimated $145.
  • Ameritas Investment Partners first reported a position in BioVie in Q2 2023 and held it in 4 quarters.
  • Ameritas Investment Partners's BioVie position peaked at $1.18K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held BioVie as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.